Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 210 (RNA5SP210) is a processed non-coding RNA pseudogene located in the human genome[2][4][6]. It is a sequence homologous to the functional 5S ribosomal RNA gene but has lost the ability to encode a functional RNA due to disabling mutations or truncations[8]. 5S rRNA is a component of the large ribosomal subunit in functional form, but pseudogenes such as RNA5SP210 are traditionally considered “junk DNA” and are generally not transcribed or translated into active products[3][8]. However, some processed rRNA pseudogenes may occasionally be transcribed, with rare cases suggesting regulatory roles in specific disease contexts (e.g., interferon regulation in alcohol-associated hepatitis[10]), but this is not generalizable or well established for RNA5SP210 specifically. As such, RNA5SP210 is not a therapeutic target, does not encode a druggable enzyme, protein, or receptor, and does not have known pharmacological or biomarker relevance[2][4][6][8]. Key points: - This entry describes a pseudogene of the 5S ribosomal RNA, not a functional gene, protein, or receptor, and thus does not qualify as a therapeutic target. - Genomic annotation pipelines (such as GENCODE and Ensembl) list RNA5SP210 as an rRNA pseudogene, and it does not play a known direct role in cellular biology nor does it interact with drugs or serve as a biomarker[2][4][6][8]. - As a pseudogene, there is inherent ambiguity regarding its function, but based on available data, there is no evidence for a canonical, clinically relevant role[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 210 (RNA5SP210).